Sajol, Aida O.
HRN: 15-47-81 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/12/2025
CEFTRIAXONE 1G (VIAL)
07/12/2025
07/19/2025
IV
2G
OD
NON-HEALING WOUND
Waiting Final Action
Indication: Empiric Type of Infection: Skin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes